The U.S. Federal Trade Commission (FTC) has slammed pharmacy benefit managers (PBMs) owned by UnitedHealth ($UNH), CVS Health ...
Regulators published their most detailed findings yet on how some of the nation’s largest companies profited from "excess" ...
The new document focuses on the influence of PBMs over the market for specialty generic drugs for illnesses like cancer, ...
Agency commissioners voted unanimously on Tuesday to publish the report, which makes similar allegations against the ...
CVS Caremark, OptumRx and St. Louis-based Express Scripts — are part of huge health conglomerates that also own insurers, ...
From 2017 to 2022, the companies marked up prices at their pharmacies by hundreds or thousands of percent, netting them $7.3 ...
The accused killer of Brian Thompson cited the industry’s failures as his motive for assassinating the UnitedHealth executive ...
An Alabama lawmaker believes prescription care management should be a legislative priority during the upcoming session.
FOX 9 Minneapolis-St. Paul on MSN1d
FTC says Optum, other prescription benefit managers inflate cancer drug prices 1,000%Prescription benefit managers have been under growing scrutiny from state and federal regulators who have accused them of ...
The nation's three largest pharmacy benefit managers have significantly marked up the prices of certain medicines, including ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Feedback